Literature DB >> 17423047

Gastrinoma (Zollinger-Ellison Syndrome) in the Dog and cat.

D H Shaw.   

Abstract

Tumors of gastrin-secreting cells (gastrinomas) result in a characteristic clinical syndrome of hypergastrinemia, which leads to gastric acid hypersecretion with subsequent severe gastrointestinal ulceration. The most common clinical signs are inappetance/anorexia, lethargy, weight loss, vomiting, diarrhea, and hypoalbuminemia. Hypergastrinemia is also seen in other disorders and caution should be used in utilizing fasting serum gastrin concentrations as the sole diagnostic criterion.

Entities:  

Year:  1988        PMID: 17423047      PMCID: PMC1680629     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  20 in total

1.  Gastrin (second of two parts).

Authors:  J H Walsh; M I Grossman
Journal:  N Engl J Med       Date:  1975-06-26       Impact factor: 91.245

2.  Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.

Authors:  R M ZOLLINGER; E H ELLISON
Journal:  Ann Surg       Date:  1955-10       Impact factor: 12.969

Review 3.  Gastrin (first of two parts).

Authors:  J H Walsh; M I Grossman
Journal:  N Engl J Med       Date:  1975-06-19       Impact factor: 91.245

4.  Peptic ulceration in a dog associated with an islet cell carcinoma of the pancreas and an elevated plasma gastrin level.

Authors:  B R Jones; M R Nicholls; R Badman
Journal:  J Small Anim Pract       Date:  1976-09       Impact factor: 1.522

5.  Effect of gastrin on electrical activity of antrum and duodenum of dogs.

Authors:  U T Strunz; C F Code; M I Grossman
Journal:  Proc Soc Exp Biol Med       Date:  1979-05

6.  Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety.

Authors:  J E McGuigan; W L Trudeau
Journal:  N Engl J Med       Date:  1968-06-13       Impact factor: 91.245

7.  Endogenous hypergastrinemia and cell proliferation in the fundic mucosa in dogs.

Authors:  G Willems; W Gepts; A Bremer
Journal:  Am J Dig Dis       Date:  1977-05

8.  Removal of gastrin by various organs in dogs.

Authors:  U T Strunz; J H Walsh; M I Grossman
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

Review 9.  Effect of gastrin on the exocrine pancreas. A review.

Authors:  H Schapiro; F E Rosato; N J Jackson; D A Dreiling
Journal:  Am J Gastroenterol       Date:  1979-01       Impact factor: 10.864

Review 10.  Zollinger-Ellison syndrome. Current concepts in diagnosis and management.

Authors:  M M Wolfe; R T Jensen
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

View more
  5 in total

Review 1.  Gastrinoma and Zollinger-Ellison syndrome in canids: a literature review and a case in a Mexican gray wolf.

Authors:  Jason D Struthers; Nick Robl; Valerie M Wong; Matti Kiupel
Journal:  J Vet Diagn Invest       Date:  2018-06-02       Impact factor: 1.279

Review 2.  Emesis in dogs: a review.

Authors:  C Elwood; P Devauchelle; J Elliott; V Freiche; A J German; M Gualtieri; E Hall; E den Hertog; R Neiger; D Peeters; X Roura; K Savary-Bataille
Journal:  J Small Anim Pract       Date:  2010-01       Impact factor: 1.522

3.  A feline case of hepatic neuroendocrine carcinoma with gastrin immunoreactivity.

Authors:  Chiaki Kita; Tetsushi Yamagami; Shigemi Kinouchi; Masayuki Nakano; Nao Nagata; Hitomi Suzuki; Yuzo Ohtake; Takuma Miyoshi; Mitsuhiro Irie; Kazuyuki Uchida
Journal:  J Vet Med Sci       Date:  2014-01-31       Impact factor: 1.267

4.  Effect of gastric acid-suppressive therapy and biological variation of serum gastrin concentrations in dogs with chronic enteropathies.

Authors:  Romy M Heilmann; Nora Berghoff; Niels Grützner; Nolie K Parnell; Jan S Suchodolski; Jörg M Steiner
Journal:  BMC Vet Res       Date:  2017-11-07       Impact factor: 2.741

5.  Prospective observational study of the use of omeprazole and maropitant citrate in veterinary specialist care.

Authors:  Rachel McCormack; Louise Olley; Barbara Glanemann; James W Swann
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.